characteristics.text: SAMN48453389
characteristics.characteristic: External Id
characteristics.text: Targeted Therapy, The Institute of Cancer Research
characteristics.characteristic: INSDC center name
characteristics.text: 2025-10-16T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-10-16T08:06:06.450Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS25015634
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS25015634
characteristics.characteristic: SRA accession
characteristics.text: MOC1
characteristics.characteristic: cell line
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: WT
characteristics.characteristic: genotype
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Mus musculus
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_10090
characteristics.characteristic: organism
characteristics.text: tumour
characteristics.characteristic: source_name
characteristics.text: tumour
characteristics.characteristic: tissue
characteristics.text: MOC1_CRT_Xevinapant_5
characteristics.characteristic: title
characteristics.text: Xevinapant/Chemoradiotherapy
characteristics.characteristic: treatment